Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.20% | -28.50% | -46.50% | -57.48% | -65.07% |
| Total Other Revenue | 28.61% | 17.96% | 12.18% | 64.26% | -4.08% |
| Total Revenue | 8.52% | -27.99% | -46.07% | -56.98% | -64.71% |
| Cost of Revenue | 0.17% | -38.55% | -55.65% | -65.30% | -70.91% |
| Gross Profit | 40.96% | 52.92% | 68.24% | 138.40% | 106.00% |
| SG&A Expenses | -7.11% | -12.03% | -12.66% | -14.20% | -9.53% |
| Depreciation & Amortization | -46.95% | 67.10% | 78.44% | 298.13% | 111.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.12% | -32.75% | -48.14% | -57.82% | -63.28% |
| Operating Income | 75.08% | 69.32% | 65.87% | 64.62% | 49.15% |
| Income Before Tax | 77.98% | 59.05% | 56.18% | 55.31% | 38.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 77.98% | 59.05% | 56.18% | 55.31% | 38.11% |
| Earnings from Discontinued Operations | 201.37% | 295.48% | -185.70% | -188.90% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.84% | 59.76% | 52.63% | 52.50% | 37.17% |
| EBIT | 75.08% | 69.32% | 65.87% | 64.62% | 49.15% |
| EBITDA | 75.47% | 69.74% | 66.27% | 65.15% | 49.53% |
| EPS Basic | 80.24% | 60.10% | 52.96% | 52.89% | 37.69% |
| Normalized Basic EPS | 75.56% | 69.48% | 66.06% | 64.91% | 49.56% |
| EPS Diluted | 78.55% | 58.67% | 52.10% | 52.89% | 37.69% |
| Normalized Diluted EPS | 75.48% | 69.42% | 66.00% | 64.91% | 49.56% |
| Average Basic Shares Outstanding | 1.85% | 1.51% | 1.19% | 0.91% | 0.82% |
| Average Diluted Shares Outstanding | 2.25% | 1.92% | 1.59% | 0.91% | 0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
